AstraZeneca has opened a new headquarters in Malaysia as part of its ongoing commitment to boost high-value skills and employment, and in bringing new…
AstraZeneca plans to better employ artificial intelligence, robots and digital applications to help change disease management in China and transition the…
Gene therapy company 4D Molecular Therapeutics has raised $90 million in venture capital funds, with plans to advance its vector platform and pipeline of…
Despite encouraging midstage data for AstraZeneca’s drug for systemic lupus erythematosus (SLE), anifrolumab has missed the target in the first of two ongoing…
Entasis Therapeutics has filed to raise up to $86 million through an IPO. The AstraZeneca spinout is seeking the money to fund a phase 3 trial of a drug to…
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
AcceptRead More